137 related articles for article (PubMed ID: 17674159)
1. Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.
Romberg B; Oussoren C; Snel CJ; Hennink WE; Storm G
Pharm Res; 2007 Dec; 24(12):2394-401. PubMed ID: 17674159
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
Romberg B; Oussoren C; Snel CJ; Carstens MG; Hennink WE; Storm G
Biochim Biophys Acta; 2007 Mar; 1768(3):737-43. PubMed ID: 17223070
[TBL] [Abstract][Full Text] [Related]
3. Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.
Romberg B; Metselaar JM; Baranyi L; Snel CJ; Bünger R; Hennink WE; Szebeni J; Storm G
Int J Pharm; 2007 Mar; 331(2):186-9. PubMed ID: 17145145
[TBL] [Abstract][Full Text] [Related]
4. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl-L-asparagine)-coated liposomes.
Romberg B; Kettenes-van den Bosch JJ; de Vringer T; Storm G; Hennink WE
Bioconjug Chem; 2006; 17(3):860-4. PubMed ID: 16704228
[TBL] [Abstract][Full Text] [Related]
6. Preparation, in vitro Characterization and Pharmacokinetic Study of Coenzyme Q10 Long-Circulating Liposomes.
Yang S
Drug Res (Stuttg); 2018 May; 68(5):270-279. PubMed ID: 29190857
[TBL] [Abstract][Full Text] [Related]
7. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics.
Schiffelers RM; Bakker-Woudenberg IA; Snijders SV; Storm G
Biochim Biophys Acta; 1999 Oct; 1421(2):329-39. PubMed ID: 10518702
[TBL] [Abstract][Full Text] [Related]
8. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
9. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
Wang XY; Ishida T; Ichihara M; Kiwada H
J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine).
Romberg B; Metselaar JM; deVringer T; Motonaga K; Kettenes-van den Bosch JJ; Oussoren C; Storm G; Hennink WE
Bioconjug Chem; 2005; 16(4):767-74. PubMed ID: 16029017
[TBL] [Abstract][Full Text] [Related]
11. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
Woodle MC; Matthay KK; Newman MS; Hidayat JE; Collins LR; Redemann C; Martin FJ; Papahadjopoulos D
Biochim Biophys Acta; 1992 Apr; 1105(2):193-200. PubMed ID: 1586658
[TBL] [Abstract][Full Text] [Related]
12. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
13. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen TM; Mehra T; Hansen C; Chin YC
Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
[TBL] [Abstract][Full Text] [Related]
14. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
15. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
16. Long-circulating sterically stabilized liposomes in the treatment of infections.
Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and pharmacokinetic characteristics of cationic liposomes.
Yeeprae W; Kawakami S; Suzuki S; Yamashita F; Hashida M
Pharmazie; 2006 Feb; 61(2):102-5. PubMed ID: 16526555
[TBL] [Abstract][Full Text] [Related]
18. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
[TBL] [Abstract][Full Text] [Related]
19. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes.
Xu H; Wang KQ; Deng YH; Chen DW
Biomaterials; 2010 Jun; 31(17):4757-63. PubMed ID: 20303164
[TBL] [Abstract][Full Text] [Related]
20. Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating.
Schiffelers RM; Bakker-Woudenberg IA; Storm G
Biochim Biophys Acta; 2000 Sep; 1468(1-2):253-61. PubMed ID: 11018669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
